Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,682 | -100,294 | -104,126 | -110,211 | -116,215 |
| Depreciation Amortization | 1,247 | 2,028 | 2,863 | 4,190 | 4,887 |
| Income taxes - deferred | N/A | -70 | 0 | N/A | N/A |
| Accounts receivable | 124 | 457 | 588 | -1,028 | 394 |
| Accounts payable and accrued liabilities | 6,203 | 1,266 | 3,119 | -995 | 10,365 |
| Other Working Capital | 171,891 | 2,292 | 4,973 | -4,821 | 10,213 |
| Other Operating Activity | 9,993 | 18,699 | 1,504 | 18,405 | 2,418 |
| Operating Cash Flow | $184,776 | $-75,622 | $-91,079 | $-94,460 | $-87,938 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -116,446 | -110,509 | 101,135 | -97,400 | 68,536 |
| PPE Investments | -575 | 2,090 | -1,591 | -407 | 1,419 |
| Investing Cash Flow | $-117,021 | $-108,419 | $99,544 | $-97,807 | $69,955 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 84,135 | N/A | N/A | N/A |
| Debt Repayment | -1,859 | -1,710 | -1,574 | -1,443 | -3,589 |
| Common Stock Issued | 114 | 202,270 | 1,084 | 38,109 | 160,781 |
| Common Stock Repurchased | -357 | -887 | -873 | -285 | -108 |
| Other Financing Activity | 70 | 0 | -26 | 0 | 0 |
| Financing Cash Flow | $-2,032 | $283,808 | $-1,389 | $36,381 | $157,084 |
| Beginning Cash Position | 137,266 | 37,499 | 30,423 | 186,309 | 47,208 |
| End Cash Position | 202,989 | 137,266 | 37,499 | 30,423 | 186,309 |
| Net Cash Flow | $65,723 | $99,767 | $7,076 | $-155,886 | $139,101 |
| Free Cash Flow | |||||
| Operating Cash Flow | 184,776 | -75,622 | -91,079 | -94,460 | -87,938 |
| Capital Expenditure | -910 | -80 | -1,721 | -492 | -1,206 |
| Free Cash Flow | 183,866 | -75,702 | -92,800 | -94,952 | -89,144 |